1. Home » 
  2. Quarterly Results » 
  3. Metropolis Healthcare Q1 Results Reach a Total Income of ₹313.36 Crore & Operating Profit ₹53.27 Crore

Metropolis Healthcare Q1 Results Reach a Total Income of ₹313.36 Crore & Operating Profit ₹53.27 Crore

Metropolis Healthcare Q1 Results with Total Income of ₹313.36 Crore, a 13.09% increase year-over-year and Operating Profit reached ₹53.27 Crore, up 26.48% YoY.  

by Ruksana

Updated Sep 27, 2024

Article continues below advertisement
Metropolis Healthcare Q1 Results Reach a Total Income of ₹313.36 Crore & Operating Profit ₹53.27 Crore

Metropolis Healthcare Q1 Results: Metropolis Healthcare recently released its Q1 financial results, showing important growth year-over-year (YoY). The total income for June 2024 reached ₹313.36 Cr., which is an increase of 13.09% YoY compared to ₹277.09 Cr. in June 2023. This growth is significant, reflecting the company's strong performance in the healthcare sector. The operating profit also improved, reaching ₹53.27 Cr., which is a 26.48% YoY rise from ₹42.12 Cr. in the same quarter last year. This indicates that Metropolis is not only generating more revenue but is also managing its expenses well.

Metropolis Healthcare’s Profit after tax has also increased, reaching ₹37.95 Cr., showing a 31.78% YoY growth from ₹28.80 Cr. in June 2023. The operating margin stands at 17.00%, a positive indicator of the company’s efficiency. In contrast, when looking at the quarter-on-quarter (QoQ) changes, total income decreased by 5.33% from ₹282.55 Cr. in March 2024. However, despite this slight drop QoQ, the YoY growth figures highlight the overall strong position of Metropolis Healthcare in the market. Overall, these results show that Metropolis Healthcare is growing steadily year-over-year, reflecting strong business practices and market demand.

Here are the Q1 results highlights for Metropolis Healthcare, presented in a table format:

Metric

Jun 24 (₹ Cr.)

Mar 23 (₹ Cr.)

QoQ Change (%)

Jun 23 (₹ Cr.)

YoY Change (%)

Total Income

313.36

282.55

-5.33

277.09

13.09

Operating Profit

53.27

46.85

-0.54

42.12

26.48

Profit After Tax

37.95

33.36

4.23

28.80

31.78

Operating Margin

17.00%

-

-

-

11.84

Selling/General/Admin Expenses

71.69

64.31

10.19

65.06

10.19

Depreciation/Amortization

25.54

23.43

-3.31

20.82

22.68

Other Operating Expenses

97.04

88.10

-8.63

89.71

8.17

Total Operating Expense

260.08

235.69

-6.26

234.97

10.69

Net Income Before Taxes

51.08

41.90

1.08

39.19

30.33

Diluted Normalized EPS

7.37

6.50

4.10

5.62

31.14

Source: Here 

For More Q1 Results check our Twitter Page

Visit our website for more Q1 results

Metropolis Healthcare Q1 Results

Metropolis Healthcare is a diagnostic company based in India that provides various laboratory services. The financial results for the quarter ending on June 30, 2024, show important information about its earnings and expenses.

Metropolis Healthcare’s total income was approximately ₹28.90 crores, which is slightly lower than the ₹29.43 crores from the same quarter last year. This decrease indicates a small decline in revenue generation. However, the total expenses also decreased to around ₹24.72 crores from ₹29.31 crores in the previous year, which suggests that the company is managing its costs effectively.

Metropolis Healthcare’s profit before tax for this quarter was about ₹4.17 crores, showing a decrease compared to ₹4.51 crores in the same quarter last year. After accounting for tax expenses of ₹1.04 crores, the net profit for the quarter was around ₹3.13 crores, compared to ₹3.18 crores last year. This slight drop in profit reflects the company’s current market challenges.

Metropolis Healthcare remains financially stable, with earnings per share (EPS) increasing to ₹6.20 from ₹5.10 last year. This means shareholders are still seeing good returns on their investment, reflecting a solid performance overall.

Here's a simplified summary of the financial results presented for the quarter ended June 30, 2024:

(Rs. in Lakhs)

Particulars

Quarter Ended 30 June 2024

Quarter Ended 30 June 2023

Year Ended 31 March 2024

1. Income

     

a) Revenue from Operations

28,613.78

29,226.68

1,10,342.54

b) Other Income

282.65

201.89

1,199.67

Total Income

28,896.43

29,428.57

1,11,542.21

2. Expenses

     

a) Cost of Materials Consumed

5,816.44

5,926.63

22,047.78

b) Laboratory Testing Charges

239.19

291.79

993.14

c) Employee Benefits Expense

6,408.79

6,112.95

24,659.70

d) Finance Costs

461.26

564.75

2,23,360

e) Depreciation and Amortisation Expense

2,475.70

2,523.75

9,073.28

f) Other Expenses

9,322.79

9,503.25

36,793.73

Total Expenses

24,724.17

29,312.92

95,801.30

3. Profit Before Tax

4,172.26

4,505.45

15,740.91

4. Tax Expenses

     

Current Tax for the Year

1,085.15

1,303.20

4,41,379

Deferred Tax Charge/Credit

(40.89)

(73.31)

(55.77)

Total Tax Expenses

1,044.31

1,327.42

4,15,193

5. Profit for the Period/Year

3,127.95

3,178.03

11,588.98

6. Other Comprehensive Income

     

Items not reclassified to profit and loss

(1.24)

(0.93)

(164.96)

7. Total Comprehensive Income

3,086.71

3,207.69

11,424.02

8. Paid-up Equity Share Capital

10,245.80

10,454.00

10,242.00

9. Other Equity

-

-

1,02,094.18

10. Earnings Per Share (EPS)

     

Basic EPS (Rs.)

6.20

5.10

2.63

Diluted EPS (Rs.)

6.07

6.18

2.55

Article continues below advertisement
Article continues below advertisement

Metropolis Healthcare Financial Metrics

Metropolis Healthcare is a well-known healthcare company in India, specializing in pathology services. The company has a market capitalization of ₹11,242 crore, indicating its overall value in the stock market. The current stock price is ₹2,194, with a highest price of ₹2,222 and a lowest price of ₹1,360 over a specific period. The stock's price-to-earnings (P/E) ratio is 82.1, showing how much investors are willing to pay for each rupee of earnings. The book value is ₹214, and it offers a dividend yield of 0.19%, providing some returns to shareholders. 

Here's a table summarizing the stock information you provided:

Metric

Value

Market Cap

₹ 11,242 Cr.

Current Price

₹ 2,194

High / Low

₹ 2,222 / ₹ 1,360

Stock P/E

82.1

Book Value

₹ 214

Dividend Yield

0.19 %

ROCE

15.8 %

ROE

12.2 %

Face Value

₹ 2.00

Article continues below advertisement
Article continues below advertisement

Quarterly Results 

Metropolis Healthcare's financial results for December 2023, March 2024, and June 2024 show important information about the company's performance. In December 2023, the company earned ₹291 crores in sales and had ₹226 crores in expenses, resulting in an operating profit of ₹65 crores with an operating profit margin (OPM) of 22%. By March 2024, sales increased to ₹331 crores, and expenses rose to ₹251 crores, leading to a higher operating profit of ₹80 crores and an OPM of 24%.

Here’s the table with only the data for December 2023, March 2024, and June 2024:

(Consolidated Figures in Rs. Crores)

Particulars

Dec 2023

Mar 2024

Jun 2024

Sales

291

331

313

Expenses

226

251

235

Operating Profit

65

80

79

OPM (%)

22%

24%

25%

Other Income

2

3

2

Interest

5

6

5

Depreciation

25

26

26

Profit Before Tax

37

51

51

Tax (%)

26%

28%

25%

Net Profit

27

37

38

EPS (in Rs)

5.30

7.11

7.41

Article continues below advertisement
Article continues below advertisement

About Metropolis Healthcare  

Metropolis Healthcare is a well-known Indian company that provides diagnostic services. It has many diagnostic centers across India and in countries like South Asia, Africa, and the Middle East. The company is famous for its accurate and reliable tests, which help in finding and monitoring diseases. Metropolis offers a wide range of tests for different health conditions.

Metropolis Healthcare focus on using advanced technology and providing excellent customer service. With a strong reputation and a loyal customer base, Metropolis Healthcare plays an important role in improving healthcare through better diagnostics and support for patients.


Metropolis Healthcare Q1 Results - FAQs

1. What services does Metropolis Healthcare offer?  

Metropolis Healthcare offers a wide range of diagnostic and laboratory services.

2. How has Metropolis Healthcare performed in Q1 of 2024?

Metropolis Healthcare reported a total income of ₹313.36 Crores in Q1 of 2024, showing a YoY growth of 13.09%.

3. What was the operating profit for Metropolis Healthcare in June 2024?

Metropolis Healthcare's operating profit in June 2024 reached ₹53.27 Crores, a 26.48% increase from the previous year.

4. How does Metropolis Healthcare manage its operating expenses?

Metropolis Healthcare has effectively managed its operating expenses, which totaled ₹260.08 Crores in June 2024.

5. What was the profit after tax for Metropolis Healthcare in Q1 2024?

The profit after tax for Metropolis Healthcare in Q1 2024 was ₹37.95 Crores, reflecting a 31.78% YoY growth.

6. What is the operating margin of Metropolis Healthcare?

Metropolis Healthcare has an operating margin of 17.00%, efficient management.

7. How does Metropolis Healthcare's performance compare quarterly?

Metropolis Healthcare experienced a QoQ decrease of 5.33% in total income from March 2024 to June 2024.

8. What is the earnings per share (EPS) for Metropolis Healthcare in June 2024?

The diluted EPS for Metropolis Healthcare in June 2024 was ₹7.37, showcasing strong profitability.

9. What was the total income reported by Metropolis Healthcare in June 2023?  

Metropolis Healthcare reported a total income of ₹277.09 Crores in June 2023.

10. How does Metropolis Healthcare's profit before tax for Q1 2024 compare to last year?  

The profit before tax for Metropolis Healthcare in Q1 2024 was ₹51.08 Crores, up from ₹39.19 Crores in the previous year.

Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.